1-6 of 6
Rosemary Mazanet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Senza5 TM CART5 : An Autologous CD5-Deleted Anti-CD5 CART Product with Enhanced Anti-T-Cell Lymphoma Activity

Adam E. Snook, Ruchi P. Patel, Guido Ghilardi, Aditya Nimmagadda, Steven Yang, Dean Qian, Patrizia Porazzi, Rosemary Mazanet, Stephen J Schuster, Stefan K. Barta, Trang Vu, Marco Ruella, Nicholas A. Siciliano
Journal: Blood
Blood (2023) 142 (Supplement 1): 3462.
https://doi.org/10.1182/blood-2023-190386
Published: 2023
Journal Articles

NKTT120 Safely Depletes iNKT Cells in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Joshua J. Field, MD MS, Elaine M. Majerus, MD PhD, Ken I. Ataga, MD, Elliott P. Vichinsky, MD, Cheryl Eaton, Rosemary Mazanet, MD PhD, David G. Nathan, MD
Journal: Blood
Blood (2015) 126 (23): 2178.
https://doi.org/10.1182/blood.V126.23.2178.2178
Published: 2015
Journal Articles

NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Elaine M. Majerus, MD PhD, Kenneth I. Ataga, MD, Elliott Vichinsky, MD, Cheryl A. Eaton, BA, Rosemary Mazanet, MD PhD, David G. Nathan, MD, Joshua J. Field, MD MS
Journal: Blood
Blood (2014) 124 (21): 2718.
https://doi.org/10.1182/blood.V124.21.2718.2718
Published: 2014
Journal Articles

Adult Patients with Stable Sickle Cell Disease Prior to Treatment with the iNKT Cell Depleting Antibody NKTT120 Have Consistent and Elevated Numbers of Activated (CD69 + ) iNKT Cells Relative to Healthy Adult Volunteers

Rosemary Mazanet, MD PhD, Robert Schaub, PhD, Felix Scheuplein, PhD, Cheryl A. Eaton, BA, Robert Mashal, MD, Joshua J. Field, MD MS
Journal: Blood
Blood (2014) 124 (21): 4097.
https://doi.org/10.1182/blood.V124.21.4097.4097
Published: 2014
Journal Articles

An MMR Control RNA for Reliable Monitoring of BCR-ABL Transcripts in Treated CML Patients.

Julie Toplin, Courtney Fuller, Linda Fletcher, Stephane Wong, Peter Maslak, Jorge Cortes, Rosemary Mazanet, Susan Branford, Timothy Hughes, Chad Galderisi, Michael Heinrich, Brian Druker, Emmanuel Beillard
Journal: Blood
Blood (2007) 110 (11): 2939.
https://doi.org/10.1182/blood.V110.11.2939.2939
Published: 2007
Journal Articles

A Pilot Phase II Trial of a Synthetic Tumor-Specific Breakpoint Peptide Vaccine in Patients with Chronic Myeloid Leukemia (CML) and Minimal Residual Disease.

Jorge Cortes, MD, James M. Reuben, MD, David Scheinberg, MD, Bang-Ning Lee, PhD, Hui Gao, PhD, Changping Li, MD, Rosemary Mazanet, MD, Dan Jones, MD, Hagop Kantarjian, MD
Journal: Blood
Blood (2006) 108 (11): 2196.
https://doi.org/10.1182/blood.V108.11.2196.2196
Published: 2006